Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 24(3)2023 Feb 03.
Article in English | MEDLINE | ID: mdl-36769303

ABSTRACT

Cell injection therapy is emerging as an alternative to treat corneal endothelial dysfunction (CED) and to avoid corneal scarring due to bullous keratopathy. However, establishing a standardized culture procedure that provides appropriate cell yield while retaining functional features remains a challenge. Here, we describe a detailed framework obtained from in vitro culture of human corneal endothelial cells (HCECs) and comparative in vivo experimental models for CED treatment with a new cell tracking approach. Two digestion methods were compared regarding HCEC morphology and adhesion. The effect of Y-27632 (ROCKi) supplementation on final cell yield was also assessed. Cell adhesion efficacy with two cell delivery systems (superparamagnetic embedding and cell suspension) was evaluated in an ex vivo human cornea model and in an in vivo rabbit CED model. The injection of supplemented culture medium or balanced salt solution (BSS) was used for the positive and negative controls, respectively. HCEC isolation with collagenase resulted in better morphology and adhesion of cultured HCEC when compared to EDTA. Y-27632 supplementation resulted in a 2.6-fold increase in final cell yield compared to the control. Ex vivo and in vivo adhesion with both cell delivery systems was confirmed by cell tracker fluorescence detection. Corneal edema and opacity improved in both animal groups treated with cultured HCEC. The corneas in the control groups remained opaque. Both HCEC delivery systems seemed comparable as treatments for CED and for the prevention of corneal scarring.


Subject(s)
Cell Tracking , Endothelium, Corneal , Animals , Humans , Rabbits , Endothelial Cells , Cicatrix/pathology , Cells, Cultured
2.
Arch Ophthalmol ; 121(10): 1369-74, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14557171

ABSTRACT

OBJECTIVE: To report the use of preserved amniotic membrane and living related corneal limbal/conjunctival transplantation in total limbal stem cell and conjunctival deficiency secondary to severe Stevens-Johnson syndrome. DESIGN: Prospective, noncomparative, interventional case series. PATIENTS AND METHODS: Ten eyes of 10 patients with total limbal stem cell and conjunctival deficiency secondary to Stevens-Johnson syndrome underwent excision of cicatricial tissue followed by amniotic membrane and living related corneal limbal/conjunctival transplantation. MAIN OUTCOME MEASURES: Reconstruction of corneal epithelium (clear appearance without epithelial defect, normal fluorescein permeability, and the absence of conjunctiva-derived goblet cells on impression cytologic testing), decrease in corneal vascularization, and improvement in visual acuity. RESULTS: During a mean follow-up of 16.7 months, satisfactory ocular surface reconstruction was obtained in 2 eyes (20%), with reduced inflammation and vascularization and a mean epithelialization time of 3 weeks. Surgical failure was observed in 4 cases (40%) and complications (infection) in 4 cases (40%). Visual acuity improved in 4 eyes (40%), remained stable in 5 eyes (50%), and decreased in 1 eye (10%). CONCLUSIONS: Amniotic membrane and living related corneal limbal/conjunctival transplantation were successful in 20% of severe cases of total limbal stem cell and conjunctival deficiency secondary to Stevens-Johnson syndrome. A high proportion of postoperative complications, in particular, infection, seemed to jeopardize a favorable outcome.


Subject(s)
Amnion/transplantation , Conjunctiva/cytology , Conjunctivitis/surgery , Epithelial Cells/transplantation , Limbus Corneae/cytology , Living Donors , Stevens-Johnson Syndrome/surgery , Adolescent , Adult , Child , Conjunctivitis/etiology , Conjunctivitis/pathology , Female , Humans , Male , Middle Aged , Ophthalmologic Surgical Procedures , Postoperative Complications , Prospective Studies , Stem Cell Transplantation , Stevens-Johnson Syndrome/complications , Stevens-Johnson Syndrome/pathology , Transplantation, Homologous , Treatment Outcome , Visual Acuity
3.
Arq. bras. oftalmol ; 66(1): 7-11, jan.-fev. 2003. ilus, tab
Article in Portuguese | LILACS | ID: lil-330836

ABSTRACT

Objetivo: O objetivo deste estudo é caracterizar por meio do exame oftalmológico os pacientes com suspeita clínica de penfigóide cicatricial ocular e apresentar os resultados obtidos com a técnica de imunofluorescência direta. Métodos: Estudo prospectivo realizado no setor de Córnea e Doenças Externas da Universidade Federal de São Paulo. Foram examinados 18 pacientes com suspeita clínica de penfigóide cicatricial ocular e realizadas biópsias de conjuntiva para o processamento da imunofluorescência direta em 13 pacientes (26 olhos), que não estavam na vigência de imunossupressão sistêmica ou terapêutica antiglaucomatosa tópica. Resultados: Segundo o estadiamento de Foster, a proporção de olhos classificados de I a IV foram: 3,8 por cento, 3,8 por cento, 15,4 por cento respectivamente. Apenas 3 (23 por cento) pacientes apresentaram imunofluorescência direta positiva. Conclusão: A maioria dos pacientes encontravam-se em estágio avançado da doença, o que denota retardo no diagnóstico. A imunofluorescência direta apresentou baixa sensibilidade em detectar depósitos de imunocomplexos na membrana basal da conjuntiva, quando comparada aos dados da literatura.


Subject(s)
Humans , Male , Female , Middle Aged , Pemphigoid, Benign Mucous Membrane , Skin Diseases, Vesiculobullous , Aged, 80 and over , Basement Membrane , Conjunctiva , Prospective Studies , Fluorescent Antibody Technique, Direct/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...